Zebra Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,206
Closed -$116K 76
2022
Q3
$116K Buy
40,206
+6,218
+18% +$22.1K 0.44% 68
2022
Q2
$118K Sell
33,988
-784
-2% -$3.07K 0.35% 86
2022
Q1
$164K Buy
34,772
+2,802
+9% +$13.7K 0.38% 102
2021
Q4
$193K Sell
31,970
-11,786
-27% -$81.9K 0.31% 124
2021
Q3
$265K Buy
+43,756
New +$493K 0.32% 115

Other funds holding MDXG

Zebra Capital Management's MDXG Position: Q4 2022 in Review

Zebra Capital Management sold out of MiMedx Group (MDXG) in Q4 2022, closing a stake of 40,206 shares — an estimated $116K sold.

Zebra Capital Management first reported a position in MDXG in Q3 2021 and held it in 5 quarters. The position peaked at $265K in Q3 2021. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2022.

  • Zebra Capital Management reported no remaining MiMedx Group position as of Q4 2022 after selling out during the quarter.
  • Zebra Capital Management sold 40,206 MiMedx Group shares in Q4 2022, an estimated $116K.
  • Zebra Capital Management first reported a position in MiMedx Group in Q3 2021 and held it in 5 quarters.
  • Zebra Capital Management's MiMedx Group position peaked at $265K in Q3 2021.
  • 152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2022.

Based on Zebra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.